Janux Therapeutics Inc (JANX)
55.33
-0.47
(-0.84%)
USD |
NASDAQ |
Nov 05, 11:47
Janux Therapeutics 1 Year Total Returns (Daily): 724.2% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 724.2% |
November 01, 2024 | 747.2% |
October 31, 2024 | 741.0% |
October 30, 2024 | 812.7% |
October 29, 2024 | 800.5% |
October 28, 2024 | 803.0% |
October 25, 2024 | 761.5% |
October 24, 2024 | 702.9% |
October 23, 2024 | 679.4% |
October 22, 2024 | 682.2% |
October 21, 2024 | 648.0% |
October 18, 2024 | 573.4% |
October 17, 2024 | 535.3% |
October 16, 2024 | 474.5% |
October 15, 2024 | 503.4% |
October 14, 2024 | 464.6% |
October 11, 2024 | 422.1% |
October 10, 2024 | 382.3% |
October 09, 2024 | 353.2% |
October 08, 2024 | 347.5% |
October 07, 2024 | 339.7% |
October 04, 2024 | 359.4% |
October 03, 2024 | 377.5% |
October 02, 2024 | 357.4% |
October 01, 2024 | 341.5% |
Date | Value |
---|---|
September 30, 2024 | 350.7% |
September 27, 2024 | 364.4% |
September 26, 2024 | 369.0% |
September 25, 2024 | 393.2% |
September 24, 2024 | 406.0% |
September 23, 2024 | 423.5% |
September 20, 2024 | 413.3% |
September 19, 2024 | 418.5% |
September 18, 2024 | 379.8% |
September 17, 2024 | 401.1% |
September 16, 2024 | 405.5% |
September 13, 2024 | 387.4% |
September 12, 2024 | 353.5% |
September 11, 2024 | 307.4% |
September 10, 2024 | 346.9% |
September 09, 2024 | 310.9% |
September 06, 2024 | 287.8% |
September 05, 2024 | 313.9% |
September 04, 2024 | 303.9% |
September 03, 2024 | 308.8% |
August 30, 2024 | 345.7% |
August 29, 2024 | 308.8% |
August 28, 2024 | 297.6% |
August 27, 2024 | 310.3% |
August 26, 2024 | 321.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.27%
Minimum
Aug 31 2022
812.7%
Maximum
Oct 30 2024
70.94%
Average
-11.97%
Median
Dec 26 2023
1 Year Total Returns (Daily) Benchmarks
Dynavax Technologies Corp | -17.09% |
Krystal Biotech Inc | 39.87% |
Arcus Biosciences Inc | -4.95% |
NovaBay Pharmaceuticals Inc | -93.97% |
Palatin Technologies Inc | -43.87% |